Table 1.
Gene signatures included in the study
| Author | Year | Signature Name (original description) | Signature names (MSIGBD§) | Patients with the signature (%)† | ||
|---|---|---|---|---|---|---|
| Signatures generated in tumor | 1 | Ye23 | 2003 | Signature of metastatic HCC | YE_LIVER_CANCER_INTRAHEPATIC_METS_UP | 14 (4.8) |
| 2 | Iizuka35 | 2003 | Signature of early intrahepatic recurrence | IIZUKA_LIVER_CANCER_EARLY_RECURRENCE_DN | NA* | |
| 3 | Lee24 | 2004 | Cluster A | LEE_LIVER_CANCER_POOR-SURVIVAL_UP, _DN | 91 (31.7) | |
| 4 | Kurokawa36 | 2004 | Signature of tumor recurrence | KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP, _DN | NA* | |
| 5 | Kaposi-Novak26 | 2006 | MET signature | NOVAK_LIVER_CANCER_MET_UP, _DN | 45 (15.6) | |
| 6 | Boyault12 | 2007 | G3 class | BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP, _DN | 90 (31.3) | |
| 7 | Chiang10 | 2008 | Proliferation class | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP, _DN | 112 (39) | |
| 8 | Villanueva | 2008 | CK19 human signature | VILLANUEVA_LIVER_CANCER_KRT19_UP, _DN | 98 (34.1) | |
| 9 | Minguez | 2008 | Vascular invasion signature | MINGUIZ_LIVER_CANCER_VASCULAR_INVASION_UP, _DN | 72 (25.1) | |
| 10 | Coulouarn25 | 2008 | Late TGFB | COULOUARN_LIVER_CANCER_TGF_BETA_LATE_VS_EARLY_UP, _DN | 70 (24.3) | |
| 11 | Woo29 | 2008 | Signature of recurrence | WOO_LIVER_CANCER_RECURRENCE_UP, _DN | 84 (29.2) | |
| 12 | Yamashita28 | 2008 | EpCAM signature | YAMASHITA_LIVER_CANCER_EPCAM_UP, _DN | 35 (12.1) | |
| 13 | Cairo14 | 2008 | Hepatoblastoma_C2 class | CAIRO_LIVER_CANCER_HEPATOBLAST_C2_POOR-PROGNOSIS_UP, _DN | 20 (6.9) | |
| 14 | Yoshioka37 | 2009 | Signature of early recurrence | YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP, _DN | NA* | |
| 15 | Hoshida27 | 2009 | Class S1 (WNT-TGFB) | HOSHIDA_LIVER_CANCER_META_ANALYSIS_SUBCLASS | 80 (27.8) | |
| 16 | Hoshida27 | 2009 | Class S2 (AKT-MYC) | HOSHIDA_LIVER_CANCER_META_ANALYSIS_SUBCLASS | 44 (15.3) | |
| 17 | Andersen11 | 2010 | CK19 rat signature | ANDERSEN_LIVER_CANCER_KRT19_UP, _DN | 95 (33.1) | |
| 18 | Woo38 | 2010 | Cholangiocarcinoma-like signature | WOO_LIVER_CANCER_CHOLANGIOCA_LIKE_UP, _DN | 115 (40.1) | |
| Signatures generated in adjacent non-tumor tissue | 19 | Hoshida6 | 2008 | Poor survival signature | HOSHIDA_LIVER_CANCER_POOR-SURVIVAL_UP, _DN | 72 (31.8)ø |
| 20 | Hoshida6 | 2008 | Late recurrence signature | HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP, _DN | 89 (39.3)ø | |
| 21 | Budhu13 | 2006 | Metastasis inclined microenvironment | BUDHU_LIVER_CANCER_METASTASIS_UP, _DN | NA* | |
| 22 | Okamato39 | 2006 | Signature of multicentric HCC | OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP, _DN | NA* | |
Patients with a predicted poor prognosis signature according to each of the gene signatures evaluated (FDR<0.05, see methods for details)
Nearest-template prediction method failed to classify any sample with the signature, based on a FDR<0,05
Prediction done on 226 patients (tissue from adjacent cirrhotic tissue available)